Matches in Wikidata for { <http://www.wikidata.org/entity/Q38029266> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- Q38029266 description "article científic" @default.
- Q38029266 description "article scientifique" @default.
- Q38029266 description "articol științific" @default.
- Q38029266 description "articolo scientifico" @default.
- Q38029266 description "artigo científico" @default.
- Q38029266 description "artigo científico" @default.
- Q38029266 description "artigo científico" @default.
- Q38029266 description "artikel ilmiah" @default.
- Q38029266 description "artikull shkencor" @default.
- Q38029266 description "artículo científico" @default.
- Q38029266 description "artículu científicu espublizáu en 2012" @default.
- Q38029266 description "bilimsel makale" @default.
- Q38029266 description "bài báo khoa học" @default.
- Q38029266 description "scienca artikolo" @default.
- Q38029266 description "scientific article published on 24 July 2012" @default.
- Q38029266 description "scientific article published on 24 July 2012" @default.
- Q38029266 description "scientific article published on 24 July 2012" @default.
- Q38029266 description "vedecký článok" @default.
- Q38029266 description "vetenskaplig artikel" @default.
- Q38029266 description "videnskabelig artikel" @default.
- Q38029266 description "vitenskapelig artikkel" @default.
- Q38029266 description "vitskapeleg artikkel" @default.
- Q38029266 description "vědecký článek" @default.
- Q38029266 description "wetenschappelijk artikel" @default.
- Q38029266 description "wissenschaftlicher Artikel" @default.
- Q38029266 description "наукова стаття, опублікована в липні 2012" @default.
- Q38029266 description "научная статья" @default.
- Q38029266 description "научни чланак" @default.
- Q38029266 description "מאמר מדעי" @default.
- Q38029266 description "مقالة علمية نشرت في 24 يوليو 2012" @default.
- Q38029266 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38029266 name "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 name "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 name "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 type Item @default.
- Q38029266 label "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 label "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 label "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 prefLabel "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 prefLabel "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 prefLabel "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 P1433 Q38029266-8214D070-599E-4CA9-AC83-699537808F9B @default.
- Q38029266 P1476 Q38029266-4CE85DB6-5E0D-4C82-9C65-20F0BA9604AE @default.
- Q38029266 P2093 Q38029266-0FFC819E-5DE1-4044-AD9C-3A4AF0FBF45E @default.
- Q38029266 P2093 Q38029266-6262E3FD-FE01-499D-BAF9-D44D0810E9C1 @default.
- Q38029266 P2093 Q38029266-669CE3A8-A2C4-49C7-B617-0963DC966688 @default.
- Q38029266 P2093 Q38029266-77AE1103-9C9A-4050-B5AE-9E29B3EAFBE0 @default.
- Q38029266 P2093 Q38029266-94F7640D-8F3F-4A51-A266-A88F362EE1FA @default.
- Q38029266 P2093 Q38029266-AB84B6A0-A656-4B62-A067-6F10F2B1CDBB @default.
- Q38029266 P2093 Q38029266-CB44DB3E-4031-4632-8981-841D58D6995B @default.
- Q38029266 P2093 Q38029266-CEC2BEC2-246F-4A31-9B7B-3A0552A87113 @default.
- Q38029266 P2093 Q38029266-CFE6A459-E6BE-4717-AAB1-69652CAB7BE9 @default.
- Q38029266 P2093 Q38029266-D1C08F75-BD6B-4FF1-99C1-FD21892AB015 @default.
- Q38029266 P304 Q38029266-20A0858F-A79D-40E3-B523-F435AF568623 @default.
- Q38029266 P31 Q38029266-871BA976-8519-44CA-8796-D11BA5864433 @default.
- Q38029266 P356 Q38029266-17A43B16-CC3B-40A8-9AD4-B93A0EBB8362 @default.
- Q38029266 P407 Q38029266-5E168A42-65DE-4AD9-BAB1-307732AC2C62 @default.
- Q38029266 P433 Q38029266-0F284B50-3477-4EF7-A709-9B7899E4C47A @default.
- Q38029266 P478 Q38029266-43AF25A3-2772-4FD3-AE4D-3385564DD1A8 @default.
- Q38029266 P577 Q38029266-8A8E3FC9-CCE1-4F85-A7A7-3AF86CBFD1EA @default.
- Q38029266 P698 Q38029266-39B7740C-9868-41F7-97DB-F60880636B9F @default.
- Q38029266 P921 Q38029266-0228499A-F599-4CD1-B509-4B8868F8F5DF @default.
- Q38029266 P921 Q38029266-B1804DA4-4052-441D-8619-2EEF87244008 @default.
- Q38029266 P356 1078-0432.CCR-11-3075 @default.
- Q38029266 P698 22829199 @default.
- Q38029266 P1433 Q332253 @default.
- Q38029266 P1476 "The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use." @default.
- Q38029266 P2093 "Elias Pean" @default.
- Q38029266 P2093 "Eric Abadie" @default.
- Q38029266 P2093 "Eva Gil Berglund" @default.
- Q38029266 P2093 "Francesco Pignatti" @default.
- Q38029266 P2093 "Jeanett Borregaard" @default.
- Q38029266 P2093 "Jens Ersbøll" @default.
- Q38029266 P2093 "Kenneth F Hofland" @default.
- Q38029266 P2093 "Rosa Giuliani" @default.
- Q38029266 P2093 "Sigrid Klaar" @default.
- Q38029266 P2093 "Tomas Salmonson" @default.
- Q38029266 P304 "4491-4497" @default.
- Q38029266 P31 Q13442814 @default.
- Q38029266 P356 "10.1158/1078-0432.CCR-11-3075" @default.
- Q38029266 P407 Q1860 @default.
- Q38029266 P433 "17" @default.
- Q38029266 P478 "18" @default.
- Q38029266 P577 "2012-07-24T00:00:00Z" @default.
- Q38029266 P698 "22829199" @default.
- Q38029266 P921 Q12859063 @default.
- Q38029266 P921 Q27882076 @default.